Across TCGA pan-cancer cohorts, MTND4LP19 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MTND4LP19’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MTND4LP19 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND4LP19 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD are the cancer types where MTND4LP19 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND4LP19 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	−0.164	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MTND4LP19 RNA expression & survival · all MTND4LP19 data types